OVER-THE-COUNTER (OTC) DRUGS
Regulatory Pathways
    ♦ Rx-to-OTC Switches
    ♦ OTC Monograph amendments
    ♦ Forced switch petitions
    ♦ Hatch-Waxman Exclusivity for OTC Switches
Labeling
    ♦ Reviews – format and substantive language requirements
    ♦ Acceptable/unacceptable claims
Promotion & Advertising
    ♦ FTC actions
    ♦ NAD proceedings
For presentations and articles on OTC Drugs, just click here ...
FDA Legal Services --  for the life of a Life Sciences company
© 2013  Michael A. Swit.  
ALL RIGHTS RESERVED.

Questions?

Contact me @ 760-815-4762
or
mswit@fdacounsel.com
Michael A. Swit
Product/Issue Specific
FDA Legal Services
Ad Hoc
FDA Legal Services
Links to My Other Services
Life Cycle
FDA Legal Services